$CNO

Tarasi Rocco F. III sold $226K of CNO

Tarasi Rocco F. III (Chief Marketing Officer) sold 4,808 shares of CNO Financial Group, Inc. (CNO) at $47.00 ($0.23M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tarasi Rocco F. III
Published Jun 4, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNO
Neutral
high confidence
Mentioned
$CNO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

Because the transaction is pre-arranged, it is generally less informative about near-term fundamentals; traders may treat it as a minor sentiment datapoint.

02

Market read

Insider selling disclosure with no accompanying earnings, guidance, deal, or regulatory event.

03

What to watch

The disclosure does not reveal whether the sale was part of routine diversification, tax planning, or a change in outlook; size is modest relative to typical liquidity.

Relevance 6/10Novelty 2/10Timing: Filed today; sale occurred on 2026-06-02

Background

The filing is an SEC Form 4 insider transaction by CNO’s Chief Marketing Officer, executed via an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$CNONeutralHigh confidence
Context

CNO’s CMO Tarasi Rocco F. III sold 4,808 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow rather than fundamentals.

Evidence & confidence

Form 4 insider sales are typically routine when under a 10b5-1 plan and the filing provides no accompanying company-specific news.

Market effects

Minimal—single-company insider transaction with no sector-wide read-across stated.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with management’s risk/valuation view, potentially weighing on sentiment.

Key entities

  • CNO Financial Group, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Tarasi Rocco F. III

    Chief Marketing Officer who sold 4,808 shares under a 10b5-1 plan.

Related articles

$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 exhibit992-06302026investo.htm EX-99.2 Document Quarterly Financial Supplement - 2Q2026 July 30, 2026 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance produ